Phase II trials show improved survival with Caprelsa (AstraZeneca) for medullary Thyroid Cancer - 16-Aug-2012
A new study shows that the chemotherapy drug vandetanib Caprelsa (vandetanib) from AstraZeneca, may extend life for some Thyroid Cancer patients. The results of Phase II trials showed that patients taking the drug lived for 11 months without the cancer progressing, compared with six months for those receiving a placebo. The report was published online Aug. 13 in the journal The Lancet Oncology. Caprelsa is approved in the USA and EU for treatment of medullary Thyroid Cancer
Related News
Roche Diagnostics launches Elecsys Calcitonin Thyroid Cancer test
Nexavar (Bayer) success in Phase III trial for Thyroid Cancer
FDA approves Cometriq (Exelixis Inc.) for treatment of Thyroid Cancer
Phase II trials show improved survival with Caprelsa (AstraZeneca) for medullary Thyroid Cancer
FDA will review cabozantinib (Exelixis Inc) as a treatment for Thyroid Ccancer on 29 November 2012
Exelixis reports results for XL 184 in Thyroid Cancer
European Commission approves Caprelsa(AstraZeneca) for medullary Thyroid Cancer
CHMP recommends Caprelsa (AstraZeneca) for Thyroid Cancer
Related Oncology Information
Oncology Clinical Guidelines
Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care
NICEProstate cancer: diagnosis and treatment
NICEOncology Clinical Trials
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Clinicaltrials.gov 08 April 2013Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy (CONKO-007)
Clinicaltrials.gov 04 April 2013Oncology Medical Journal Abstracts
Bone mass density, fracture history, self-reported osteoporosis as proxy variables for estrogen and the risk of non-small-cell lung cancer—A population based cohort study, the HUNT study: Are proxy variables friends or faults?
Lung Cancer 24 April 2013Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
Lung Cancer 22 April 2013Oncology Medical Apps
CCO Oncology inPractice
Free
Cancer Signs and Symptoms
Free
Related Oncology Drugs
- EFUDIX CREAM
- DAUNOXOME INJECTION (LIPOSOMAL DAUNORUBICIN)
- ONKOTRONE INJECTION
- AROMASIN
- CYTARABINE INJECTION SOLUTION 20MG/ML AND 100MG/ML
- TOMUDEX
- XALUPRINE
- MITOMYCIN C
- CASODEX 150 MG FILM-COATED TABLETS.
- VINCRISTINE SULPHATE 1 MG/ML INJECTION
- MABTHERA 100MG AND 500MG CONCENTRATE FOR SOLUTION FOR INFUSION
- TESTOSTERONE ENANTATE AMPOULES
- CYPROSTAT 50MG
- ZAVEDOS
- PROSTAP 3 DCS
- CAMPTO 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TASIGNA 200 MG HARD CAPSULES
- ERWINASE
- MEGACE 160 MG TABLETS
- FIRMAGON 80MG INJECTION
- TYVERB
- ZALTRAP 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TEMODAL CAPSULES
- XELODA 150MG AND 500MG FILM-COATED TABLETS
- BICALUTAMIDE 150MG FILM-COATED TABLETS
- VEPESID SOFT CAPSULES 50 MG AND 100 MG
- NAVELBINE 10 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ROFERON-A 18MIU/0.6ML CARTRIDGE
- SUTENT 12.5MG, 25MG, 37.5MG AND 50MG HARD CAPSULES
- MYOCET
- CAELYX 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ERBITUX 5MG/ML SOLUTION FOR INFUSION
- CYCLOPHOSPHAMIDE 50 TABLETS
- GEMCITABINE 200 MG POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 1 G POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 2 G POWDER FOR SOLUTION FOR INFUSION
- HALAVEN 0.44 MG/ML SOLUTION FOR INJECTION
- PROSTAP SR
- ATRIANCE 5 MG/ML SOLUTION FOR INFUSION
- FASLODEX 250 MG SOLUTION FOR INJECTION
- ARIMIDEX 1MG FILM-COATED TABLET
- PHOTOFRIN
- PROCARBAZINE CAPSULES 50MG
- ISOVORIN
- DACARBAZINE 100MG, 200MG, 500MG, 1000MG
- LEUSTAT INJECTION
- VESANOID 10MG SOFT CAPSULES
- HYCAMTIN 1MG AND 4MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- HYDREA 500 MG HARD CAPSULES
- BICALUTAMIDE 50MG FILM-COATED TABLETS
- DOXORUBICIN 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ESTRACYT CAPSULES
- HERCEPTIN 150MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- MITOXANTRONE (MITOZANTRONE) 2 MG/ML STERILE CONCENTRATE
- GRANISETRON
- PERJETA 420 MG CONCENTRATE FOR SOLUTION FOR INFUSION
- HYCAMTIN 0.25MG AND 1 MG HARD CAPSULE
- PROSTAP SR DCS
- FEMARA
- UFTORAL HARD CAPSULES
- NIPENT 10 MG POWDER FOR SOLUTION FOR INJECTION, POWDER FOR SOLUTION FOR INFUSION
- FLUOROURACIL 25 MG/ML INJECTION
- EVOLTRA 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- VOTRIENT 200 MG FILM-COATED TABLETS
- LEUKERAN TABLETS 2 MG
- UTOVLAN
- CARDIOXANE 500MG POWDER FOR SOLUTION FOR INFUSION
- MAXTREX TABLETS 2.5 MG
- SOLTAMOX
- ONCOTICE
- ELOXATIN 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ETOPOPHOS 100MG POWDER FOR SOLUTION FOR INJECTION
- TOPOTECAN 4 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- VINBLASTINE SULPHATE 1 MG/ML INJECTION
- ZOLADEX
- VOTRIENT 200 MG FILM-COATED TABLETS
- IRESSA 250MG FILM-COATED TABLETS
- GEMZAR 200MG POWDER FOR SOLUTION FOR INFUSION, GEMZAR 1000MG POWDER FOR SOLUTION FOR INFUSION
- PROLEUKIN
- PARAPLATIN
- LEVOFOLINIC ACID 50 MG/ML SOLUTION FOR INJECTION OR INFUSION
- REVLIMID
- NASTROSA 1MG FILM-COATED TABLETS
- CYPROSTAT 100MG
- NOVGOS
- TAXOTERE 80MG/4ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TEPADINA 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- PHARMORUBICIN
- AVASTIN 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ROFERON-A PRE-FILLED SYRINGE
- FARESTON
- VELCADE 3.5 MG POWDER FOR SOLUTION FOR INJECTION.
- FIRMAGON 120MG INJECTION
- XAGRID 0.5MG HARD CAPSULE
- NEXAVAR 200MG FILM-COATED TABLETS
- PROSTAP 3 LEUPRORELIN ACETATE DEPOT INJECTION 11.25MG
- TARCEVA 25MG, 100MG AND 150MG FILM-COATED TABLETS
- TAMOFEN (CARCINOMA)
- SPRYCEL 20MG, 50MG, 80MG, 100MG AND 140MG FILM COATED TABLETS
- TAXOTERE 160MG/8ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TAXCEUS 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- GLIVEC
- TAXOL
- YONDELIS SOLUTION FOR INFUSION.
- FLUDARA ORAL 10 MG FILM-COATED TABLET
- PROVERA TABLETS 100 MG
- TAXOTERE 20MG/1ML CONCENTRATE FOR SOLUTION FOR INFUSION
- CARBOPLATIN 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- KYTRIL TABLETS 1MG AND 2MG
- GLIADEL 7.7MG IMPLANT
- VOTRIENT 200 MG AND 400 MG FILM COATED TABLETS
- MAXTREX TABLETS 10 MG
- CASODEX 50 MG FILM-COATED TABLETS
- JEVTANA
Advert for Healthcare Professionals only